Bay Harbor Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Buy
225
+7
+3% +$7.1K 0.05% 55
2025
Q4
$234K Buy
218
+23
+12% +$22K 0.06% 55
2025
Q3
$149K Buy
195
+17
+10% +$12.7K 0.04% 64
2025
Q2
$139K Buy
178
+47
+36% +$36.5K 0.04% 64
2025
Q1
$108K Buy
131
+9
+7% +$7.49K 0.03% 67
2024
Q4
$94.2K Buy
122
+30
+33% +$24.8K 0.03% 76
2024
Q3
$81.5K Sell
92
-4
-4% -$3.6K 0.03% 77
2024
Q2
$86.9K Hold
96
0.03% 75
2024
Q1
$74.7K Buy
96
+21
+28% +$14.9K 0.03% 88
2023
Q4
$43.7K Buy
+75
New +$43.8K 0.02% 105
2021
Q1
Sell
-22
Closed -$4K 337
2020
Q4
$4K Buy
+22
New +$3.29K ﹤0.01% 297

Other funds holding LLY

Bay Harbor Wealth Management's LLY Position: Q1 2026 in Review

Bay Harbor Wealth Management increased its Eli Lilly (LLY) stake by 3.2% in Q1 2026, buying an estimated $7.1K and bringing the position to 225 shares worth $207K. The position accounts for 0.05% of the portfolio, ranked #55.

Bay Harbor Wealth Management first reported a position in LLY in Q4 2020 and has held it in 11 quarters since. The position peaked at $234K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bay Harbor Wealth Management held 225 shares of Eli Lilly worth $207K as of Q1 2026.
  • Bay Harbor Wealth Management bought 7 Eli Lilly shares in Q1 2026, an estimated $7.1K.
  • Eli Lilly made up 0.05% of Bay Harbor Wealth Management's portfolio in Q1 2026, its #55 holding.
  • Bay Harbor Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 11 quarters since.
  • Bay Harbor Wealth Management's Eli Lilly position peaked at $234K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.